Nathan Lee

Senior Director, Gene Therapy CMC at Poseida Therapeutics

Speaker

"Nathan is currently Senior Director of CMC at Poseida Therapeutics. At Poseida, he leads all aspects of the CMC product development lifecycle for Poseida’s gene therapy programs. He has 15+ years of experience specializing in development, manufacturing, and CMC strategy leadership. He has experience ranging from early development through to commercial lifecycle support. Nathan has worked with numerous therapeutic modalities including large molecules (Fc fusion, enzymes, monoclonal antibodies), viral vector (AAV) and nonviral (mRNA/sgRNA/LNP, in vivo and ex vivo) gene therapies. Nathan has an ME in Chemical Engineering from Tufts University and a BS in Biochemistry from the University of New Hampshire."